July 3, 2017

Stocks In News - USFDA

Stocks In News - USFDA
Strides Shasun:-

  • The Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Promethazine Hydrochloride tablets USP, 12.5 mg, 25 mg and 50 mg.
  • The US market for Promethazine Hydrochloride tablets USP, 12.5 mg, 25 mg and 50 mg is approximately USD 17 million.


Wockhardt
  • Wockhardt gets US FDA nod for Olopatadine hydrochloride solution (used to prevent itchy, red & watery eyes due to allergies)

No comments:

Post a Comment